Unite Us and Ride Health Partner to Improve Access to Transportation Services for New Yorkers

2 years ago

The Collaborative Initiative with Social Care Networks Will Overcome Obstacles to Vital Services Following New York State's Approval of the…

Safe Supply Streaming Announces Landmark Coca Powder and Extract Product Shipment During the Third Wave of Drug Policy Reforms

2 years ago

Toronto, Ontario--(Newsfile Corp. - February 15, 2024) - Safe Supply Streaming Co. Ltd. (CSE: SPLY) (FSE: QM4) (OTCQB: SSPLF) ("Safe Supply" or…

Cardio Diagnostics Holdings, Inc. Expands HeartRisk™ Platform Offering to Diverse Markets in Conjunction with Nationwide Rollout

2 years ago

Transformative Cardiovascular Risk Management Solutions Extend Beyond Traditional Sectors to Include Federal and State Correctional Facilities, Broker and Benefits Organizations,…

NervGen Pharma on Track to Complete Enrollment, Deliver Data Readout in Phase 1b/2a Clinical Trial for NVG-291 in Spinal Cord Injury

2 years ago

On track to complete enrollment of the chronic cohort in Q2 2024Data readout from chronic cohort expected in Q3 2024Planning…

BioHarvest Sciences Engages MZ Group to Lead Strategic Investor Relations and Shareholder Communications Program

2 years ago

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - February 15, 2024) - BioHarvest Sciences Inc., (CSE: BHSC) (OTCQB: CNVCF) (FSE:…

Sibannac, Inc. Provides New Shareholder Update

2 years ago

Scottsdale, Arizona--(Newsfile Corp. - February 15, 2024) - Sibannac, Inc. (OTC Pink: SNNC), a Nevada corporation (the "Company"), announced the…

Revolutionizing Veteran Care: Get Well Unveils Breakthrough Outcomes in Veterans Health Administration (VHA) Collaboration

2 years ago

Following the VHA's Expansion of Get Well Solutions Across 13,000 Inpatient Beds, Recent Findings Have Underscored a Dramatic Enhancement in…

Adial Pharmaceuticals to Present at the Winter Wrap-Up MicroCap Rodeo Conference on February 20

2 years ago

CHARLOTTESVILLE, VA / ACCESSWIRE / February 15, 2024 / Adial Pharmaceuticals, Inc. (NASDAQ:ADIL)(NASDAQ:ADILW) ("Adial" or the "Company"), a clinical-stage biopharmaceutical…

Jaguar Health Announces FDA Agrees with Clinical Trial Protocol for Full Approval of Canalevia-CA1 for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs

2 years ago

Canalevia®-CA1 is currently FDA conditionally approved for treatment of CID in dogs and is the first and only treatment for…

Ensysce Biosciences Announces Publication of Clinical Bioequivalence Manuscript

2 years ago

Publication Details Positive Results of Clinical Study PF614-102SAN DIEGO, CA / ACCESSWIRE / February 15, 2024 / Ensysce Biosciences, Inc.…